• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor.

作者信息

Park B E

出版信息

Surg Neurol. 1979 Jan;11(1):73-80.

PMID:451853
Abstract

An increased incidence of communicating hydrocephalus following subarachnoid hemorrhage has been observed on the neurosurgical service at Vanderbilt University Hospital during the past four years. This increase parallels the time interval during which epsilon amino caproic acid (Amicar) has been used in the preoperative regimen for intracranial aneurysms to prevent recurrent hemorrhage. Radiographic studies of 48 patients with subarachnoid hemorrhage not receiving Amicar were compared with 46 similar patients treated with this antifibrinolytic agent. In the series not treated with Amicar, a 17% incidence of dilated lateral ventricles was found, with 10% of the series being symptomatic from their hydrocephalus. A total of 43% of patients in the group treated with Amicar demonstrated dilated ventricles, with 31% of the group clinically symptomatic. Mechanisms of action of Amicar possibly implicated in this increased incidence of hydrocephalus are discussed.

摘要

相似文献

1
Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor.
Surg Neurol. 1979 Jan;11(1):73-80.
2
Cerebral thrombosis associated with Amicar therapy.与氨基己酸治疗相关的脑血栓形成。
Radiology. 1979 Jun;131(3):687-9. doi: 10.1148/131.3.687.
3
Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.接受ε-氨基己酸治疗的颅内动脉瘤破裂患者血浆纤溶活性的定量测定:治疗可能并发症与纤溶抑制程度的关系
Neurosurgery. 1984 Jan;14(1):57-63. doi: 10.1227/00006123-198401000-00012.
4
Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases.与ε-氨基己酸(EACA)治疗相关的肌病。两例报告。
J Neurosurg. 1978 Oct;49(4):597-601. doi: 10.3171/jns.1978.49.4.0597.
5
An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus.抗纤维蛋白溶解疗法对蛛网膜下腔出血后脑血管痉挛和脑积水影响的实验研究
Surg Neurol. 1984 Feb;21(2):159-64. doi: 10.1016/0090-3019(84)90335-5.
6
Cerebral complication of antifibrinolytic therapy in the treatment of ruptured intracranial aneurysm. Animal experiment and a review of literature.抗纤维蛋白溶解疗法治疗颅内动脉瘤破裂的脑部并发症。动物实验及文献综述。
Eur Neurol. 1980;19(2):77-84. doi: 10.1159/000115131.
7
Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report.与氨基己酸治疗及急性肾动脉血栓形成相关的复发性蛛网膜下腔出血。病例报告。
J Neurosurg. 1979 Jul;51(1):94-7. doi: 10.3171/jns.1979.51.1.0094.
8
Experimental epsilon-aminocaproic acid (EACA) administration in the presence of subarachnoid blood.在蛛网膜下腔出血情况下进行实验性氨甲环酸(EACA)给药。
J Neurosurg. 1971 Dec;35(6):657-63. doi: 10.3171/jns.1971.35.6.0657.
9
Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report.
J Neurosurg. 1980 Nov;53(5):690-2. doi: 10.3171/jns.1980.53.5.0690.
10
Symptomatic hydrocephalus following aneurysmal subarachnoid hemorrhage.
Surg Neurol. 1984 Apr;21(4):402-4. doi: 10.1016/0090-3019(84)90121-6.

引用本文的文献

1
Risk of Shunt Dependent Hydrocephalus after Treatment of Ruptured Intracranial Aneurysms : Surgical Clipping versus Endovascular Coiling According to Fisher Grading System.颅内动脉瘤破裂治疗后依赖分流的脑积水风险:根据Fisher分级系统比较手术夹闭与血管内栓塞治疗
J Korean Neurosurg Soc. 2010 Oct;48(4):313-8. doi: 10.3340/jkns.2010.48.4.313. Epub 2010 Oct 30.
2
Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.抗纤维蛋白溶解疗法预防蛛网膜下腔出血后早期再出血
Neurocrit Care. 2008;8(3):418-26. doi: 10.1007/s12028-008-9088-5.
3
Management of subarachnoid haemorrhage.
蛛网膜下腔出血的管理
J Neurol Neurosurg Psychiatry. 1993 Sep;56(9):947-59. doi: 10.1136/jnnp.56.9.947.
4
Effect of antifibrinolytic therapy on subarachnoid fibrosis in dogs after experimental subarachnoid haemorrhage.抗纤维蛋白溶解疗法对实验性蛛网膜下腔出血后犬蛛网膜下腔纤维化的影响。
Acta Neurochir (Wien). 1980;54(1-2):17-24. doi: 10.1007/BF01401939.
5
Antifibrinolytic treatment in subarachnoid haemorrhage: present state.蛛网膜下腔出血的抗纤溶治疗:现状
Acta Neurochir (Wien). 1982;63(1-4):233-44. doi: 10.1007/BF01728877.
6
Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.氨甲环酸在动脉瘤性蛛网膜下腔出血中的应用
J Clin Pathol Suppl (R Coll Pathol). 1980;14:68-73.
7
Subarachnoid haemorrhage.蛛网膜下腔出血
Br Med J (Clin Res Ed). 1981 Nov 21;283(6303):1347-8. doi: 10.1136/bmj.283.6303.1347.
8
Antifibrinolytic agents in subarachnoid haemorrhage.蛛网膜下腔出血中的抗纤溶药物
J Neurol. 1987 Jan;234(1):1-8. doi: 10.1007/BF00314000.
9
Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study.破裂性脑动脉瘤抗纤溶治疗后的再出血、缺血和脑积水:一项回顾性临床研究。
Acta Neurochir (Wien). 1988;93(3-4):77-87. doi: 10.1007/BF01402885.
10
Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.抗纤维蛋白溶解疗法在破裂颅内动脉瘤治疗中的益处与风险。一项双盲安慰剂对照研究。
Acta Neurochir (Wien). 1990;102(1-2):1-10. doi: 10.1007/BF01402177.